You are here

SBIR Phase I: Structure-based drug discovery for intrinsically disordered proteins

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 2026142
Agency Tracking Number: 2026142
Amount: $255,872.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: PT
Solicitation Number: N/A
Timeline
Solicitation Year: 2020
Award Year: 2020
Award Start Date (Proposal Award Date): 2020-09-01
Award End Date (Contract End Date): 2021-08-31
Small Business Information
BOWDOIN ST
BOSTON, MA 02108
United States
DUNS: 117079833
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 Virginia Burger
Business Contact
 Virginia Burger
Research Institution
N/A
Abstract

The broader impact/commercialization potential of this Small Business Innovation Research (SBIR) Phase I project is to enable drug discovery for life-threatening diseases. A group of proteins involved in cancers and neurodegenerative disorders, as well as

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government